Pharmacogenomics. Going from genome to pill.
Robert F
RF
Service
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D015415:Biomarkers; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics / Q000378:metabolism; D017277:Drug Approval; D004345:Drug Industry; D004358:Drug Therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D005820:Genetic Testing; D005838:Genotype; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010597:Pharmacogenetics; D043922:Toxicogenetics; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D015415:Biomarkers; D004364:Pharmaceutical Preparations; D003577:Cytochrome P-450 Enzyme System